Phosphatidylserine Blockade Limits Systemic Dissemination of Leishmania Amazonensis Amastigotes
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/4561938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Arieli Bernardo Portugal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Immunoparasitology Laboratory, Medical Sciences Institute, Federal University of Rio de Janeiro, Macaé, RJ, Brazil, ufrj.br. Hauptthemen laut MEDLINE: Phosphatidylserines, Leishmania mexicana, Leishmaniasis, Leishmania. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Rio de Janeiro.
Abstract (Originalsprache)
Leishmania amazonensis is associated with cases of cutaneous, disseminated, diffuse, mucosal, and visceral leishmaniasis (VL). The mechanisms underlying its ability to persist and spread after the initial clinical cure are unclear, although intrinsic characteristics of the parasite and the host may be involved. Phosphatidylserine (PS) is a pathogenic factor in both experimental models and in patients. It is related to macrophage infection, regulation of inflammatory and immune responses, and the extent and severity of the clinical outcomes of the disease. In a murine model of systemic infection, treatment with PS‐targeting antagonist antibodies significantly reduced parasite burden in the spleen. In parallel, the number and size of disseminated skin lesions were consistently reduced. These effects correlated with a substantial decrease in interleukin‐10 (IL‐10) and transforming growth factor‐β (TGF‐β) production by splenocytes stimulated with leishmanial antigens, indicating a reversal of the regulatory immune profile commonly associated with chronic infection. These findings support a critical role for PS in the dissemination and visceralization of Leishmania amazonensis , highlighting its contribution to immune evasion and the pathogenesis of severe disease forms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunoparasitology Laboratory, Medical Sciences Institute, Federal University of Rio de Janeiro, Macaé, RJ, Brazil, ufrj.br.
- Cell and Tissue Biology Laboratory, North Fluminense State University, Campos Dos Goytacazes, RJ, Brazil.
ORCID-Profile: Arieli Bernardo Portugal, Suzana Passos Chaves, Renato Augusto DaMatta, João Luiz Mendes Wanderley
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Rio de Janeiro
Zitieren
APA
Portugal, A. B., Chaves, S. P., DaMatta, R. A., & Wanderley, J. L. M. (2026). Phosphatidylserine Blockade Limits Systemic Dissemination of Leishmania Amazonensis Amastigotes. Journal of Immunology Research. https://doi.org/10.1155/jimr/4561938
Vancouver
Portugal AB, Chaves SP, DaMatta RA, Wanderley JLM. Phosphatidylserine Blockade Limits Systemic Dissemination of Leishmania Amazonensis Amastigotes. Journal of Immunology Research. 2026. doi:10.1155/jimr/4561938
BibTeX
@article{Portugal2026,
author = {Portugal, Arieli Bernardo and Chaves, Suzana Passos and DaMatta, Renato Augusto and Wanderley, João Luiz Mendes},
title = {Phosphatidylserine Blockade Limits Systemic Dissemination of Leishmania Amazonensis Amastigotes},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/4561938}
}
EUVIMED